Naloxegol for Opioid-Induced Constipation: Mechanism of Action and Clinical Implications

被引：0
|
作者：
Tack, Jan F.
Cimen, Ali
Khanh Bui
Sostek, Mark
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)31850-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1597
引用
收藏
页码：S538 / S538
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate response
    Tack, Jan
    Lappalainen, Jaakko
    Diva, Ulysses
    Tummala, Raj
    Sostek, Mark
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2015, 3 (05) : 471 - 480
  • [42] Naloxegol (Movantik®) Provides Rapid and Sustained Improvement of Opioid-Induced Constipation Symptoms Irrespective of Opioid Dose
    McLeskey, Charles
    Gudin, Jeffrey
    Adler, Jeremy
    Rockett, Carol
    Jamindar, Mansi
    Rauck, Richard
    Webster, Lynn
    Mallick-Searle, Theresa
    PAIN MANAGEMENT NURSING, 2023, 24 (02) : 237 - 237
  • [43] Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation
    Webster, L.
    Chey, W. D.
    Tack, J.
    Lappalainen, J.
    Diva, U.
    Sostek, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (07) : 771 - 779
  • [44] Opioid-induced constipation
    Plaisance, L
    Ellis, JA
    AMERICAN JOURNAL OF NURSING, 2002, 102 (03) : 72 - 73
  • [45] Opioid-induced Constipation
    Vallerand, April Hazard
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2017, 13 (02): : 170 - 174
  • [46] Opioid-induced constipation
    Gyawali, Bishal
    Hayashi, Naomi
    Tsukuura, Hiroaki
    Honda, Kazunori
    Shimokata, Tomoya
    Ando, Yuichi
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (11) : 1331 - 1338
  • [47] Opioid-Induced Constipation
    Webster, Lynn R.
    PAIN MEDICINE, 2015, 16 : S16 - S21
  • [48] Opioid-induced constipation: advances and clinical guidance
    Nelson, Alfred D.
    Camilleri, Michael
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (02) : 121 - 134
  • [49] Treatment with naloxegol versus placebo: pain assessment in patients with noncancer pain and opioid-induced constipation
    Webster, L.
    Lappalainen, J.
    Diva, U.
    Tummala, R.
    Sostek, M.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [50] NALOXEGOL: THE FIRST ORALLY ADMINISTERED, PERIPHERALLY ACTING, μ OPIOID RECEPTOR ANTAGONIST, APPROVED FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION
    Corsetti, M.
    Tack, J.
    DRUGS OF TODAY, 2015, 51 (08) : 479 - 489
12345